Minimal Access vs. Open Spine Surgery in Patients With Metastatic Spinal Cord Compression - A One-Center Randomized Controlled Trial

Anticancer Res. 2020 Oct;40(10):5673-5678. doi: 10.21873/anticanres.114581.

Abstract

Background/aim: We conducted a randomized controlled trial to investigate whether minimally access spine surgery (MASS) is less morbid than open surgery (OS) in patients with metastatic spinal cord compression (MSCC).

Patients and methods: A total of 49 MSCC patients were included in the trial. The outcome measures were bleeding (L), operation time (min), re-operations and prolonged wound healing.

Results: The median age was 67 years (range=42-85 years) and 40% were men. The peri-operative blood loss in the MASS-group was significantly lower than that in the OS-group; 0.175L vs. 0.500L, (p=0.002). The median operation time for MASS was 142 min (range=72-203 min) vs. 103 (range=59-435 min) for OS (p=0.001). There was no significant difference between the two groups concerning revision surgery or delayed wound healing.

Conclusion: The MASS technique in MSCC patients is associated with less blood loss, but a longer operation time when compared to the OS technique.

Keywords: Metastatic spinal cord compression; bleeding; minimal access surgery; operation time; spinal metastases; spinal surgery; vertebral metastases.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Blood Loss, Surgical / physiopathology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures / adverse effects
  • Minimally Invasive Surgical Procedures / methods*
  • Operative Time
  • Outcome Assessment, Health Care
  • Reoperation / methods
  • Spinal Cord Compression / blood
  • Spinal Cord Compression / physiopathology
  • Spinal Cord Compression / surgery*
  • Spinal Dysraphism / blood
  • Spinal Dysraphism / physiopathology
  • Spinal Dysraphism / surgery*
  • Spinal Neoplasms / blood
  • Spinal Neoplasms / physiopathology
  • Spinal Neoplasms / secondary
  • Spinal Neoplasms / surgery*
  • Treatment Outcome